ClinicalTrials.govpublic full text
Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma
metastatic transitional cell cancer of the renal pelvis and ureter, recurrent bladder cancer, recurrent transitional cell cancer of the renal pelvis and ureter, recurrent urethral cancer, stage iii bladder cancer, stage iii urethral cancer, stage iv bladder cancer, stage iv urethral cancer, transitional cell carcinoma of the bladder, ureter cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 888190
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.